Ifinatamab deruxtecan shows promising results in advanced small cell lung cancer

New­ly ap­point­ed CEO Joe Pa­pa out­lined his vi­sion for Emer­gent BioSo­lu­tions, which in­cludes wind­ing down two fa­cil­i­ties and lay­ing off 300 em­ploy­ees to save $80

As­traZeneca is the lat­est phar­ma com­pa­ny to chal­lenge the In­fla­tion Re­duc­tion Act in court, this time ze­ro­ing in on the law’s pro­vi­sions around or­phan drugs.